BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35069495)

  • 1. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients.
    Blumenthal MJ; Lambarey H; Chetram A; Riou C; Wilkinson RJ; Schäfer G
    Front Microbiol; 2021; 12():795555. PubMed ID: 35069495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual detection of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.
    Labo N; Marshall V; Miley W; Davis E; McCann B; Stolka KB; Ndom P; Hemingway-Foday JJ; Abassora M; Newton R; Smith JS; Whitby D
    Int J Cancer; 2019 Nov; 145(9):2468-2477. PubMed ID: 31265124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi's Sarcoma Patients in South Africa.
    Tibenderana RM; Blumenthal MJ; Bukajumbe E; Schäfer G; Mohamed Z
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
    Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
    J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients.
    Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Orrell C; Schäfer G
    EBioMedicine; 2024 Feb; 100():104986. PubMed ID: 38306893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies.
    Chinna P; Bratl K; Lambarey H; Blumenthal MJ; Schäfer G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
    Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
    Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008.
    Sabourin KR; Mugisha J; Asiki G; Nalwoga A; Labo N; Miley W; Beyer R; Rochford R; Johnston TW; Newton R; Whitby D
    Infect Agent Cancer; 2023 Sep; 18(1):55. PubMed ID: 37775773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda.
    Nalwoga A; Marshall V; Miley W; Labo N; Whitby D; Newton R; Rochford R
    Infect Agent Cancer; 2023 Jun; 18(1):38. PubMed ID: 37316814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
    Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
    AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
    Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
    N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
    Chen J; Schaller S; Jardetzky TS; Longnecker R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
    Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
    N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.
    Zheng D; Wan J; Cho YG; Wang L; Chiou CJ; Pai S; Woodard C; Zhu J; Liao G; Martinez-Maza O; Qian J; Zhu H; Hayward GS; Ambinder RF; Hayward SD
    J Infect Dis; 2011 Dec; 204(11):1683-91. PubMed ID: 21990424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways.
    Chen J; Dai L; Kendrick S; Post SR; Qin Z
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0239521. PubMed ID: 35041508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
    Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
    Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.
    Gorres KL; Daigle D; Mohanram S; Miller G
    J Virol; 2014 Jul; 88(14):8028-44. PubMed ID: 24807711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
    Otu AA
    J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.